Stay updated on Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the government funding status notice and Revision: v3.4.1; these are footer/system-level updates that do not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:39:45.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a government funding lapse notice indicating the NIH Clinical Center is open and where to check status. Updated site version to v3.4.1 and removed v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-03T23:50:27.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a glossary display; updated the QC-related label to 'Last Update Submitted that Met QC Criteria' and revised FEAR Act data and version text (Revision: v3.4.0), while removing the prior wording (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T21:28:52.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page no longer lists the condition Head and neck squamous cell carcinoma and removes related topics such as MedlinePlus Genetics.
    Difference
    0.1%
    Check dated 2026-01-06T03:21:00.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Added related topic links: Head and neck squamous cell carcinoma and MedlinePlus Genetics; no changes to the study details or core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-30T02:28:29.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Locations section added with a comprehensive list of sites (Arizona, California, Colorado, Connecticut, Florida, Illinois, Kansas, Louisiana, Maryland, Michigan, Minnesota, New York, Oregon, Pennsylvania, South Carolina, Texas, Virginia, Ontario). The update replaces the previous per-location headings and removes the HHS Vulnerability Disclosure link.
    Difference
    2%
    Check dated 2025-12-23T00:46:58.000Z thumbnail image

Stay in the know with updates to Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page.